Cibc Private Wealth Group, LLC Bio Atla, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $56.1 Billion
- Q3 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Bio Atla, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,290 shares of BCAB stock, worth $1,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,290
Previous 1,290
-0.0%
Holding current value
$1,148
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BCAB
# of Institutions
45Shares Held
13.6MCall Options Held
67.8KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.84MShares$4.3 Million1.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.73 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.37MShares$1.22 Million0.04% of portfolio
-
Acadian Asset Management LLC Boston, MA930KShares$828,1110.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny801KShares$712,5610.0% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $32.3M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...